SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Bone Metastases in Subjects With Advanced Cancer
Interventions
RADIATION

Conventional Radiotherapy (CRT)

The conventional radiotherapy group, that is, the control group, administering conventional external beam radiotherapy with a dose of 30 Gy in 10 fractions to the bone metastasis lesions.

RADIATION

SCART (Stereotactic Central Ablative Radiation Therapy ) /SFRT(Spatially Fractionated Radiation Therapy )

"Stereotactic Central Ablative Radiotherapy (SCART): When using SCART to treat bone metastases with associated soft tissue components, the gross tumor volume (GTV) of the bone metastases must be accurately delineated according to the guidelines. The GTV are contracted to derive the SCART-Treatment Volume (STV). An initial dose of 8-12 Gy in a single fraction is delivered to the STV, followed by a dose of 25-40 Gy in 5 fractions to the clinical target volume (CTV). Spatially Fractionated Radiation Therapy (SFRT): The GTV are reduced to form a LATTICE target area. Several vertices are uniformly contoured along the edges of the LATTICE. A dose of 8-12 Gy in a single fraction is delivered to the vertices, followed by a dose of 25-40 Gy in 5 fractions to the CTV."

Trial Locations (1)

0531

RECRUITING

Shandong Cancer Hospital and Institute, Jinan

All Listed Sponsors
lead

Shandong Cancer Hospital and Institute

OTHER

NCT06987370 - SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue | Biotech Hunter | Biotech Hunter